Variable | Estimate | Standard variation | p value | VIF |
---|---|---|---|---|
Antibody titer at 2Â weeks (multivariable regression analysis) | ||||
Age | − 0.01 | 0.01 | 0.15 | 1.18 |
DM | − 0.20 | 0.12 | 0.10 | 1.05 |
COPD | 0.32 | 0.19 | 0.09 | 1.02 |
BUN | − 0.02 | 0.02 | 0.27 | 1.20 |
Cerebrovascular disease | − 0.30 | 0.23 | 0.19 | 1.02 |
Antibody titer at 2Â weeks (stepwise regression analysis) | ||||
Age | − 0.02 | 0.01 | 0.005 | 1.00 |
DM | − 0.26 | 0.12 | 0.04 | 1.02 |
COPD | 0.32 | 0.16 | 0.05 | 1.02 |
Reduction rate of antibody titer (multivariable regression analysis) | ||||
BMI | 0.06 | 0.03 | 0.05 | 1.12 |
Alb | − 0.60 | 0.38 | 0.12 | 1.61 |
Sex | − 0.06 | 0.14 | 0.69 | 1.22 |
Age | − 0.01 | 0.01 | 0.44 | 1.22 |
CRP | 0.09 | 0.63 | 0.89 | 1.44 |
IgG | − 0.0001 | 0.0004 | 0.88 | 1.51 |
UA | 0.10 | 0.10 | 0.29 | 1.15 |
Reduction rate of antibody titer (stepwise regression analysis) | ||||
BMI | 0.07 | 0.03 | 0.03 | 1.00 |
Alb | − 0.49 | 0.30 | 0.11 | 1.00 |